Recombinant Human Erythropoietin (r-HuEPO) as an Adjunct to Radiation Therapy and Cisplatin for Patients with Stages II-B, III and IV-A Carcinoma of the Cervix, Phase II

Closed

Phase

Accrual

98%

Published

Abbreviated Title

Recombinant Human Erythropoietin (r-HuEPO) as an Adjunct to Radiation Therapy and Cisplatin for Patients with Stages II-B, III and IV-A Carcinoma of the Cervix, Phase II

Activated

12/15/1994

Closed

03/01/1999

Research committees

Gynecologic Cancer

Publication Information Expand/Collapse

2004

Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study

RS Lavey;PY Liu;BE Greer;WR Robinson;PC Chang;RB Wynn;ME Conrad;C Jiang;M Markman;DS Alberts Gynecologic Oncology 95:145-151

2003

Recombinant human erythropoietin (EPO) as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study

RS Lavey;PY Liu;BE Greer;WR Robinson;CC Pui;RB Wynn;ME Conrad;C Jiang;M Markman;DS Alberts Int Journal of Radiation Oncology Bio Phy 57(2) Suppl:S190-S191(#110)

2001

Recombinant Human Erythropoietin (EPO) as an adjunct to radiation therapy (RT) and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group (SWOG) study

RS Lavey;PY Liu;BE Greer;PC Cheng;WR Robinson;BJ Monk;RB Wynn;ME Conrad;DS Alberts Gynecologic Oncology 80(2):276-277(#6)

2000

Recombinant human eryghropoietin (EPO) as an adjunct to radiation therapy (RT) and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study

RS Lavey;PY Liu;BE Greer;PC Cheng;WR Robinson;BJ Monk;RB Wynn;ME Conrad;D Alberts Radiotherapy & Oncology 56(Suppl.1):S92(#330)